Clinical trial
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
NCT00455247 · Société des Produits Nestlé (SPN), Industry · Completed
Key facts
| NCT number | NCT00455247 |
|---|---|
| Title | Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects |
| Lead sponsor | Société des Produits Nestlé (SPN), Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Digestive Cancers |
| Intervention type | Drug |
| Interventions | Glutamine |
| Start date | Oct 1, 2007 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | Apr 3, 2007 |
| Last update posted | Jun 5, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: